Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-02-02 @ 5:39 AM
Study NCT ID:
NCT03841734
Status:
UNKNOWN
Last Update Posted:
2019-02-15
First Post:
2019-02-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO
Sponsor:
Centre Hospitalier Universitaire de Nice
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
18-AOIP-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None